Logo

Bayer HealthCare to use TEMIS' Luxid Text-Analysis Software

Sep 18, 2007
NEW YORK (GenomeWeb News) — TEMIS today said Bayer HealthCare will use its text-analytics software in its drug-discovery programs.    
 
The software, called Luxid for Life Sciences, addresses information-management problems “through automated domain-specific knowledge extraction, flexible analytics, documents classification, relationships representation and retrieval capabilities,” TEMIS said.
 
Bayer HC’s information services team will use the software to conduct searches of the literature and patents requested by internal customers, TEMIS said.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.